erythropoietin peptide peptide - EPOpeptidefor sale Erythropoietin (EPO) mimetic peptide (EMP Understanding Erythropoietin Peptide: A Comprehensive Overview

EMP17peptide The realm of biological molecules offers fascinating insights into the body's intricate regulatory mechanisms. Among these, the erythropoietin peptide stands out for its crucial role in red blood cell production and its potential as a therapeutic agent. This article delves into the multifaceted nature of erythropoietin peptides, exploring their biological functions, therapeutic applications, and the ongoing research that continues to expand our understanding.

The Core Function: Erythropoiesis and Beyond

At its heart, erythropoietin (EPO) is a glycoprotein cytokine primarily produced by the kidneys in response to cellular hypoxia. Its principal function is to regulate erythrocyte proliferation and differentiation, thereby maintaining a physiological level of circulating red blood cells. This process, known as erythropoiesis, is vital for oxygen transport throughout the body. When oxygen levels drop, EPO production increases, signaling the bone marrow to ramp up red blood cell synthesis.

However, the scope of erythropoietin extends beyond its traditional role. Emerging research highlights its potential as a tissue protective agent. Studies suggest that EPO can trigger anti-inflammatory and anti-apoptotic processes, which are instrumental in delimiting injury and promoting tissue repair. This has opened avenues for investigating its use in conditions beyond anemia.

Erythropoietin-Mimetic Peptides: Harnessing the Power of EPO

The complexity and size of the native erythropoietin hormone have spurred the development of smaller, synthetic molecules that can mimic its activity. These are known as erythropoietin mimetic peptides (EMP)Erythropoietin. These peptides are designed to bind to and activate the erythropoietin receptor, thereby eliciting similar biological responses to the natural hormone.

One prominent example is EMP17, an erythropoietin (EPO)-mimetic peptide. EMP17, and other similar peptides, are engineered to replicate the crucial functions of EPO, offering potential advantages in terms of stability, cost-effectiveness, and targeted delivery. Research into these peptide mimetic of erythropoietin (EPO) is actively exploring their efficacy in various therapeutic contexts.

Therapeutic Potential and Applications

The ability of erythropoietin and its peptide mimetics to stimulate red blood cell production has significant implications for treating conditions characterized by anemia.Erythropoietin Soluble Receptor Peptide >90% (SDS- ... This includes anemia associated with chronic kidney disease, chemotherapy, and certain autoimmune disordersPeptidemimetic oferythropoietin(EPO). It has been described to be an excellent starting point for the design of compounds witherythropoietin(EPO) mimetic .... Furthermore, the capacity of EPO to correct anemia in patients with pure red-cell aplasia caused by antierythropoietin antibodies underscores its targeted therapeutic potential.

Beyond hematology, the non-hematopoietic effects of erythropoietin-derived peptides are gaining traction.作者：B Cho·2022·被引用次数：18—Shorterythropoietin-derivedpeptideenhances memory, improves long-term potentiation, and counteracts amyloid beta-induced pathology. Neurobiol. Aging, 81 ... Research indicates that certain erythropoietin-derived peptides can enhance memory, improve long-term potentiation, and counteract amyloid beta-induced pathology. These findings suggest a potential role in neurodegenerative diseases. Moreover, studies have shown that these peptides can prevent ischemic brain injury and neuroinflammation, opening doors for their application in stroke and other neurological conditions. The research by Yoo et alErythropoietinis commonly referred to as hematopoietin or hemopoietin. It is also known in its abbreviated form of EPO. This is a glycoprotein cytokine that's .... demonstrated that both MK-X and EPO attenuate the glutamate-induced increase in calcium influx and concomitant excitotoxicity in cultured cortical neurons, further supporting their neuroprotective capabilities作者：M McCarthy·1996·被引用次数：3—The 20 aminoacid, 2kDapeptideis far smaller than erythopoetin, a 34 kDa hormone. Furthermore, it does not share sequence or structural homology with the ....

Scientific Scrutiny and Research Advancements

The scientific community has dedicated considerable effort to understanding the intricate workings of erythropoietin peptides. Peptide mapping analysis of erythropoietin (EPO), for instance, has been crucial in elucidating the structural features responsible for its biological activity. This detailed analysis, focusing on complex N- and O-linked glycans, provides fundamental insights into EPO's molecular structure.

The development of erythropoietin mimetic peptide has been an ongoing area of research since the mid-1990s. Early work by McCarthy in 1996 described a 20 amino acid, 2kDa peptide that, despite being significantly smaller than the 34 kDa EPO hormone and lacking sequence or structural homology, could mimic its function.EPO/Erythropoietin, Human Subsequent research has focused on enhancing the potency and affinity of these mimetics.Small peptide designed that can mimic erythropoietin For example, a dimeric form of an erythropoietin mimetic peptide (EMP) was synthesized and demonstrated a 100-fold increased affinity for the erythropoietin receptor作者：DL Johnson·1998·被引用次数：141—The ability of thispeptideto effectively serve as a mimetic capable of the induction of EPO-responsive cell proliferation appears to reside within a single .... More recent investigations have identified eleven-amino acid peptides that mimic the erythropoietin α-helix B, showcasing the continuous refinement in peptide design.作者：NC Wrighton·1997·被引用次数：179—We have synthesized a chemically defined, dimeric form of anerythropoietin mimetic peptide(EMP) that displays 100-fold increased affinity for the ...

Key Entities and Terminology

Throughout this discussion, several key terms and entities have emerged:

* Erythropoietin (EPO): The primary hormone regulating red blood cell production. It is also known as hematopoietin or hemopoietin.

* Erythropoietin-Mimetic Peptide (EMP): Synthetic peptides designed to replicate the functions of EPO.Erythropoietinis commonly referred to as hematopoietin or hemopoietin. It is also known in its abbreviated form of EPO. This is a glycoprotein cytokine that's ...

* EMP17: A specific erythropoietin (EPO)-mimetic peptide.

* Peptide: A short chain of amino acidsEMP17 is an erythropoietin (EPO)-mimetic peptide. Erythropoietin (EPO) is the hormone involved in red blood cell production, which activates its receptor..

* Erythropoiesis: The process of red blood cell production.

* Red blood cell production: The primary function of EPO.

* Anemia: A condition characterized by a deficiency of red blood cells.

* Pure red-cell aplasia: A specific type of anemia where the bone marrow fails to produce red blood cells.

* Neuroinflammation: Inflammation in the nervous system.

* Ischemic brain injury: Brain damage caused by a lack of blood flow.Small Peptides as Potent Mimetics of the Protein Hormone ...

* MK-X: An erythropoietin-derived peptide studied for its neuroprotective effects.

* Erythropoietin receptor: The cellular receptor that EPO and its mimetics bind toSmall Peptides as Potent Mimetics of the Protein Hormone ....

* Glycoprotein cytokine: A type of protein that plays a role in cell signaling and immune responses作者：B Cho·2022·被引用次数：18—Shorterythropoietin-derivedpeptideenhances memory, improves long-term potentiation, and counteracts amyloid beta-induced pathology. Neurobiol. Aging, 81 ....

* Erythrocyte proliferation and differentiation: The processes of cell division and specialization for red blood cells.

* Peptide mapping analysis: A technique used to study the structure of peptides.

* Erythropoietin (EPO) is a 165 amino acid protein: Refers to the size of the native EPO protein作者：NC Wrighton·1997·被引用次数：179—We have synthesized a chemically defined, dimeric form of anerythropoietin mimetic peptide(EMP) that displays 100-fold increased affinity for the ....

* Erythropoietin (EPO) mimetic peptide (EMP): A general term for EPO-mimicking peptides.

* Peptides that mimic the spatial structure of the erythropoietin α-helix B: A specific class of EMPs作者：NC Wrighton·1996·被引用次数：1065—Random phage displaypeptidelibraries and affinity selective methods were used to isolate smallpeptidesthat bind to and activate the receptor for the ....

* Peptide: A general term referring to short chains of amino acids.

* Erythropoietin: The natural hormone.

In conclusion, the erythropoietin peptide and its synthetic counterparts represent a significant area of scientific exploration.EPO - Erythropoietin - Homo sapiens (Human) | UniProtKB From their fundamental role in oxygen transport to their emerging therapeutic applications in neurological disorders and beyond, these molecules continue to unveil new possibilities in medicine and biology. The ongoing research into erythropoietin mimetic peptides promises to yield innovative treatments and a deeper understanding of the body's complex physiological systems.